from2028 Activists Investors Trump Politicians Serenity Citrini Semianalysis Trade Arbitrage Search

$PTGX:NASDAQ · Protagonist Therapeutics Inc

Sector: health

Conviction from: NASDAQCitrini

Protagonist Therapeutics is a biopharmaceutical company that discovers and develops peptide-based therapies for inflammatory, blood, and other diseases.

2 tracked filer(s) hold this · 1 opened, 0 added, 0 trimmed in 31-MAR-2026

Aggregate 13FScore 73 — mean of 2 scored holder(s) · buyers (new/add) avg 55. Higher = the smart money in this name has the better track record.

Filer	13FScore	This quarter	Shares	Value	% of their book
Bridgewater	55	New buy	5,276	$556,090	0.0%
Stanley Druckenmiller / Duquesne	91	Holds (flat)	159,700	$16,832	0.5%

Beyond 13F — activists, insiders, politicians & research

Trump & executive branch trades all Trump/exec trades →

1 disclosed trade(s) by 1 filer(s).

Trade date	Who	Type	Amount
2026-07-01	Trump, Donald J President	SELL	$15,001 - $50,000	PTR

Citrini Research coverage report library →

Report	Date	Stance
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami	2025-05-28	LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.